PROPENSITY TO PRESCRIBE

Serial Number 88957774
Registration 6533452
700

Registration Progress

Application Filed
Jun 10, 2020
Under Examination
Approved for Publication
Aug 10, 2021
Published for Opposition
Aug 10, 2021
Registered
Oct 26, 2021

Trademark Image

PROPENSITY TO PRESCRIBE

Basic Information

Serial Number
88957774
Registration Number
6533452
Filing Date
June 10, 2020
Registration Date
October 26, 2021
Published for Opposition
August 10, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 26, 2021
Registration
Registered
Classes
005 009 042

Rights Holder

Diaceutics plc

99
Address
55-59 Adelaide Street
BELFAST BT28FE
GB

Ownership History

Diaceutics plc

Original Applicant
99
BELFAST GB

Diaceutics plc

Owner at Publication
99
BELFAST GB

Diaceutics plc

Original Registrant
99
BELFAST GB

Legal Representation

Attorney
MARGARET M. POWERS

USPTO Deadlines

Next Deadline
643 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20211026)
Due Date
October 26, 2027
Grace Period Ends
April 26, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description Documents
Oct 26, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 10, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 10, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 21, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 7, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 29, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 24, 2021 ALIE A ASSIGNED TO LIE Loading...
Apr 13, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 18, 2021 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Mar 18, 2021 GEAP O EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Mar 18, 2021 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Mar 18, 2021 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Sep 21, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 21, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 14, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 5, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 13, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes
Class 009
Downloadable computer software for use in relation to medicine and pharmaceutical research and development services for data management, data analysis, data manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data in the field of medicine and pharmaceutical testing, research and development; downloadable computer software for use in relation to business networking and content management in the field of medicine and pharmaceutical testing, research and development; downloadable computer software applications for data management and visualisation, for generating reports, charts and dashboards in the field of medicine and pharmaceutical research and development
Class 042
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing services, namely, computer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; design and development of computer databases; software design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis services, namely, data analysis for medicine and pharmaceutical testing, research and development purposes; information, advice and consultancy in relation to all the aforesaid services, namely, providing information in the field of research and development of pharmaceutical preparations; Software as a service (SAAS) services featuring software in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Software as a service (SAAS) services featuring software in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Software as a service (SAAS) services featuring software in relation to data management and visualisation, for generating reports, charts and dashboards; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management, data analysis, data manipulation, and medicine and pharmaceutical testing, research and development services; Platform as a service (PAAS) featuring computer software platforms for use in relation to communication between laboratory networks and diagnostic and pharmaceutical companies; Platform as a service (PAAS) featuring computer software platforms for use in relation to data management and visualisation for generating reports, charts and dashboards; information, advice and consultancy in relation to all the aforesaid services

Classification

International Classes
005 009 042